{"entity":{"id":"zhejiang-hisun","kind":"company","name":"Zhejiang Hisun Pharmaceutical","aka":["Zhejiang Hisun Pharmaceutical Co. Ltd.","Hisun","浙江海正药业"],"tldr":"Hisun is a large Chinese maker of active ingredients and generic injectables, founded in 1952 in Taizhou, whose biosimilar and generic cancer medicines go through the phase 3 trials it sponsors.","summary":"Zhejiang Hisun Pharmaceutical, headquartered in Taizhou, Zhejiang, and listed in Shanghai, is one of China's largest producers of active pharmaceutical ingredients and sterile injectables, including anthracyclines and other cytotoxics, and has moved into biosimilars such as adalimumab and bevacizumab. ClinicalTrials.gov lists Hisun as lead sponsor of a phase 3 cancer trial.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.hisunpharm.com"},{"label":"ClinicalTrials.gov: trials led by Zhejiang Hisun Pharmaceutical Co. Ltd.","url":"https://clinicaltrials.gov/search?lead=Zhejiang%20Hisun%20Pharmaceutical%20Co.%20Ltd."},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q30260852"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial","biosimilar"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Taizhou","country":"CN","companyType":"pharma","website":"http://www.hisunpharm.com","founded":1952,"stage":"public","investors":[],"funding":[]},"route":"/companies/zhejiang-hisun/","neighbours":{"term":[{"id":"biosimilar","kind":"term","name":"Biosimilar","route":"/terms/biosimilar/"},{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}